Glucose degradation products in peritoneal dialysis: From bench to bedside

Kidney and Blood Pressure Research

Volumn 26, Issue 2, 2003, Pages 113-117

  Jörres, Achim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Biocompatibility; Glucose degradation products; Peritoneal dialysis fluids

Indexed keywords

GLUCOSE; GLUCOSE DEGRADATION PRODUCT; PERITONEAL DIALYSIS FLUID;

AMBULATORY CARE; BED; CELL FUNCTION; CLINICAL PRACTICE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HUMAN; HYPEROSMOLALITY; INSTRUMENT STERILIZATION; MEDICAL RESEARCH; MEMBRANE; OUTCOMES RESEARCH; PERITONEAL DIALYSIS; PERITONEUM; PERITONEUM CELL; PH; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

DIALYSIS SOLUTIONS; GLUCOSE; HUMANS; KIDNEY FAILURE, CHRONIC; MEMBRANES, ARTIFICIAL; PERITONEAL DIALYSIS; STERILIZATION;

EID: 0038315190     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070993     Document Type: Review

References (49)

1. Cooker LA, Luneburg P, Faict D, Choo C, Holmes CJ: Reduced glucose degradation products in bicarbonate/lactate-buffered peritoneal dialysis solutions produced in two-chambered bags. Perit Dial Int 1997;17:373-378.
2. Di Paolo N, Sacchi G, De Mia M, Gaggiotti E, Capotondo L, Rossi P, Bernini M, Pucci AM, Ibba L, Sabatelli P, et al: Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986;44:204-211.
3. Dobbie JW: Morphology of the peritoneum in CAPD. Blood Purif 1989;7:74-85.
4. Dobbie JW, Lloyd JK, Gall CA: Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. Adv Perit Dial 1990;6:3-12.
5. Feriani M: Bicarbonate-buffered CAPD solutions: From clinical trials to clinical practice. Perit Dial Int 1997;17(suppl 2):51-55.
6. Feriani M, Carobi C, La Greca G, Buoncris-tiani U, Passlick Deetjen J: Clinical experience with a 39 mmol/l bicarbonate-buffered peritoneal dialysis solution. Perit Dial Int 1997;17:17-21.
7. Feriani M, Kirchgessner J, La Greca G, Passlick-Deetjen J: Randomized long-term evaluation of bicarbonate-buffered CAPD solution. Kidney Int 1998;54:1731-1738.
8. Henderson IS, Couper IA, Lumsden A: Potentially irritant glucose metabolites in unused CAPD fluid; in Maher JF, Winchester JF (eds): Frontiers in Peritoneal Dialysis. New York, Field, Rich Assoc Inc, 1986, pp 261-264.
9. Henderson IS, Couper IA, Lumsden A: The effect of shelf life of peritoneal dialysis fluids on ultrafiltration in CAPD; in La Greca G (ed): Peritoneal Dialysis. Milan, Wichtig, 1986, pp 85-86.
10. Holmes CJ: Biocompatibility of peritoneal dialysis solutions. Perit Dial Int 1993;13:88-94.
11. Honda K, Nitta K, Horita S, Yumura W, Nihei H, Nagai R, Ikeda K, Horiuchi S: Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultrafiltration. Nephrol Dial Transplant 1999;14:1541-1549.
12. Inagi R, Miyata T, Yamamoto T, Suzuki D, Urakami K, Saito A, Van Ypersele DS, Kurokawa K: Glucose degradation product methyl-glyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: Role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis. FEBS Lett 1999;463:260-264.
13. Jonasson P, Bagge U, Wieslander A, Braide M: Heat-sterilized PD fluid blocks leukocyte adhesion and increases flow velocity in rat peritoneal venules. Perit Dial Int 1996;16(suppl 1):137-140.
14. Jonasson P, Braide M: Acute in vivo toxicity of heat-sterilized glucose peritoneal dialysis fluids to rat peritoneal macrophages. Perit Dial Int 1998;18:376-381.
15. Jörres A, Bender TO, Finn A, Witowski J, Fröhlich S, Gahl GM, Frei U, Keck H, Passlick-Deetjen J: Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function. Kidney Int 1998;54:2184-2193.
16. Jörres A, Gahl GM, Frei U: Peritoneal dialysis fluid biocompatibility: Does it really matter? Kidney Int Suppl 1994;48:79-86.
17. Jörres A, Williams JD, Topley N: Peritoneal dialysis solution biocompatibility: Inhibitory mechanisms and recent studies with bicarbonate-buffered solutions. Perit Dial Int 1997;17(suppl 2):42-46.
18. Kjellstrand P, Martinson E, Wieslander A, Holmquist B: Development of toxic degradation products during heat sterilization of glucose-containing fluids for peritoneal dialysis: Influence of time and temperature. Perit Dial Int 1995;15:26-32.
19. Lage C, Pischetsrieder M, Aufricht C, Jörres A, Schilling H, Passlick-Deetjen J: First in vitro and in vivo experiences with stay-safe balance, a pH-neutral solution in a dual-chambered bag. Perit Dial Int 2000;20(suppl 5):28-32.
20. Lamb EJ, Cattell WR, Dawnay AB: In vitro formation of advanced glycation end products in peritoneal dialysis fluid. Kidney Int 1995;47:1768-1774.
21. Linden T, Cohen A, Deppisch R, Kjellstrand P, Wieslander A: 3,4-Dideoxyglucosone-3-ene (3,4-DGE): A cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney Int 2002;62:697-703.
22. Linden T, Forsback G, Deppisch R, Henle T, Wieslander A: 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis. Perit Dial Int 1998;18:290-293.
23. Mackenzie RK, Holmes CJ, Moseley A, Jenkins JP, Williams JD, Coles GA, Faict D, Topley N: Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNF-α secretion. J Am Soc Nephrol 1998;9:1499-1506.
24. Mackenzie RK, Jones S, Moseley A, Holmes CJ, Argyle R, Williams JD, Coles GA, Pu K, Faict D, Topley N: In vivo exposure to bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function. Am J Kidney Dis 2000;35:112-121.
25. Mactier RA, Sprosen TS, Gokal R, Williams PF, Lindbergh M, Naik RB, Wrege U, Grontoft KC, Larsson R, Berglund J, Tranaeus AP, Faict D: Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int 1998;53:1061-1067.
26. Martinson E, Wieslander AP, Kjellstrand PT, Boberg U: Toxicity of heat-sterilized peritoneal dialysis fluids is derived from degradation of glucose. ASAIO J 1992;38:M370-M372.
27. Martis L, Henderson LW: Impact of terminal heat sterilization on the quality of peritoneal dialysis solutions. Blood Purif 1997;15:54-60.
28. Mortier S, De Vriese AS, Van DV, Schaub TP, Passlick-Deetjen J, Lameire NH: Hemody-namic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration and glucose degradation products. J Am Soc Nephrol 2002;13:480-489.
29. Musi B, Carlsson O, Rippe A, Wieslander A, Rippe B: Effects of acidity, glucose degradation products, and dialysis fluid buffer choice on peritoneal solute and fluid transport in rats. Perit Dial Int 1998;18:303-310.
30. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, Hayakawa H, Osaka N, Yamamoto H, Ogawa A, Kubo H, Shigematsu T, Sakai O, Horiuchi S: Immuno-histochemical detection of advanced glycosylation end- products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997;51:182-186.
31. Nilsson Thorell CB, Muscalu N, Andren AH, Kjellstrand PT, Wieslander AP: Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int 1993;13:208-213.
32. Niwa H, Takeda A, Wakai M, Miyata T, Yasuda Y, Mitsuma T, Kurokawa K, Sobue G: Accelerated formation of N-ε-(carboxymethyl)lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons. Biochem Biophys Res Commun 1998;248:93-97.
33. Pischetsrieder M: Chemistry of glucose and biochemical pathways of biological interest. Perit Dial Int 2000;20(suppl 2):26-30.
34. Rippe B, Simonsen O, Heimburger O, Christensson A, Haraldsson B, Stelin G, Weiss L, Nielsen FD, Bro S, Friedberg M, Wieslander A: Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 2001;59:348-357.
35. Rubin J, Herrera GA, Collins D: An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991;18:97-102.
36. Schalkwijk CG, Posthuma N, ten Brink HJ, ter Wee PM, Teerlink T: Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids. Perit Dial Int 1999;19:325-333.
37. Sundaram S, Cendoroglo M, Cooker LA, Jaber BL, Faict D, Holmes CJ, Pereira BJ: Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro. Am J Kidney Dis 1997;30:680-689.
38. Topley N, Kaur D, Petersen MM, Jörres A, Passlick Deetjen J, Coles GA, Williams JD: Biocompatibility of bicarbonate-buffered peritoneal dialysis fluids: Influence on mesothelial cell and neutrophil function. Kidney Int 1996;49:1447-1456.
39. Topley N, Kaur D, Petersen MM, Jörres A, Williams JD, Faict D, Holmes CJ: In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function. J Am Soc Nephrol 1996;7:218-224.
40. Tranaeus A: A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution - Clinical benefits. The Bicarbonate/Lactate Study Group. Perit Dial Int 2000;20:516-523.
41. Wells Knecht KJ, Brinkmann E, Wells Knecht MC, Litchfield JE, Ahmed MU, Reddy S, Zyzak DV, Thorpe SR, Baynes JW: New biomarkers of Maillard reaction damage to proteins. Nephrol Dial Transplant 1996;11(suppl 5):41-47.
42. Wieslander A, Linden T: Glucose degradation and cytotoxicity in PD fluids. Perit Dial Int 1996;16(suppl 1):114-118.
43. Wieslander AP, Andren AH, Nilsson Thorell C, Muscalu N, Kjellstrand PT, Rippe B: Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro? Perit Dial Int 1995;15:348-352.
44. Wieslander AP, Kjellstrand PT, Rippe B: Heat sterilization of glucose-containing fluids for peritoneal dialysis: Biological consequences of chemical alterations. Perit Dial Int 1995;15:S52-59.
45. Wieslander AP, Nordin MK, Kjellstrand PT, Boberg UC: Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991;40:77-79.
46. Wieslander AP, Nordin MK, Martinson E, Kjellstrand PT, Boberg UC: Heat-sterilized PD fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. Clin Nephrol 1993;39:343-348.
47. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002;13:470-479.
48. Witowski J, Korybalska K, Wisniewska J, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jörres A: Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 2000;11:729-739.
49. Witowski J, Pawlaczyk K, Breborowicz A, Scheuren A, Kuzlan-Pawlaczyk M, Wisniewska J, Polubinska A, Friess H, Gahl GM, Frei U, Jörres A: IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO-α chemokine from mesothelial cells. J Immunol 2000;165:5814-5821.